| Trial ID: | L0463 |
| Source ID: | NCT04049396
|
| Associated Drug: |
Berberine
|
| Title: |
The Effect of Berberine on Lipid Profile, Liver Enzymes and Fasting Blood Glucose in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD): A Randomized Controlled Trial
|
| Acronym: |
NAFLD
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non-Alcoholic Fatty Liver Disease
|
| Interventions: |
Other: Berberine
|
| Outcome Measures: |
Change from baseline of Alanine Aminotransferase (ALT);Change from baseline of Aspartate Aminotransferase (AST);Change from baseline of Alkaline Phosphatase( ALP)Change from baseline of fasting blood sugar(FBS);Change from baseline of total cholesterol (TC);Change from baseline of LDL-Cholesterol;Change from baseline of HDL - Cholesterol;Change from baseline of Triglyceride (TG)
|
| Sponsor/Collaborators: |
Lida Nejati
|
| Gender: |
All
|
| Age: |
18 Years65 Years
|
| Phases: |
Not applicable
|
| Enrollment: |
50
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
|
| Start Date: |
21/07/2019
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
12 December 2020
|
| Locations: |
Iran, Islamic Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT04049396
|
